Concepedia

Yunhang Guo

YG

Statistics

Publications

6

Citations

512

H-Index

6

Active since

2008

Affiliations

BeiGene (China)(Current)

Yunhang Guo is an author at BeiGene (China) specializing in tumor biology, cancer research, and immunology.

ORCID

Top concepts

Publications per year

2008–2024

6

Publications

6

Discovery of Zanubrutinib (BGB-3111), a Novel, Potent, and Selective Covalent Inhibitor of Bruton’s Tyrosine Kinase

Yunhang Guo, Ye Liu, Nan Hu et al. · Journal of Medicinal Chemistry · 2019 · 332 citations · Full text

Sonrotoclax overcomes BCL2 G101V mutation–induced venetoclax resistance in preclinical models of hematologic malignancy

Jiuyang Liu, Shuran Li, Qin Wang et al. · Blood · 2024 · 61 citations · Full text

Abstract 2597: BGB-3111 is a novel and highly selective Bruton's tyrosine kinase (BTK) inhibitor

Na Li, Zhijian Sun, Ye Liu et al. · Cancer Research · 2015 · 47 citations

, , +21

Discovery of the Clinical Candidate Sonrotoclax (BGB-11417), a Highly Potent and Selective Inhibitor for Both WT and G101V Mutant Bcl-2

Yunhang Guo · Journal of Medicinal Chemistry · 2024 · 29 citations · Full text

Preparation and biological evaluation of 99mTc-CO-MIBI as myocardial perfusion imaging agent

Xiangji Chen, Yunhang Guo, Qiuyan Zhang et al. · Journal of Organometallic Chemistry · 2008 · 25 citations

, , +9

1–5 of 6